top of page

Edison Explains Psychedelics

Updated: Nov 9, 2021

Edison Group looks at the ongoing revolution of hallucinogenic drug research. Edison’s Sean Conroy states that recent preliminary clinical evidence has shown psilocybin to have significant improvements over the available therapy for treatment-resistant depression and major depressive disorder.


Edison-explains-Psychedelics-Final-draft-2-_0-1
.pdf
Download PDF • 206KB


1 view0 comments

Recent Posts

See All
bottom of page